Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Obiageli Nnodu

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
The Lancet. Haematology|October 4, 2023
Sickle cell disease strategies and priorities - Authors' replyFrédéric B Piel, Michael R DeBaun, Obiageli Nnodu, et al.
Current Stem Cell Research & Therapy|February 22, 2022
HSC and miRNA Regulation with Implication for Foetal Haemoglobin Induction in Beta HaemoglobinopathiesChinwe Okeke, Ufele Silas, Obiageli Nnodu, et al.
Lancet (London, England)|July 13, 2024
Priorities for sickle cell disease global research and implementationAmbroise Wonkam, Nchangwi Syntia Munung, Aldiouma Guindo, et al.
BMJ Open|January 29, 2024
Protocol for a comparative cross-sectional study on characterisation of auditory impairment in sickle cell disease and sickle cell trait and its impact on health-related quality of life in NigeriaTitus S Ibekwe, Christine Rogers, Obiageli Nnodu, et al.
Pediatric Blood & Cancer|August 4, 2020
Accidental hydroxyurea overdosage in a child with sickle cell anemia: An African experienceUche Nnebe-Agumadu, Innocent Adogah Adebayo, Obiageli Nnodu, et al.
The Lancet. Haematology|October 6, 2024
The Global Fund should extend its mandate to include universal access to hydroxyureaIsaac Odame, Lêon Tshilolo, Julie Makani, et al.
Pediatric Blood & Cancer|March 31, 2021
Hydroxyurea in children with sickle cell disease in a resource-poor setting: Monitoring and effects of therapy. A practical perspectiveUche Nnebe-Agumadu, Innocent Adebayo, Ifeanyi Erigbuem, et al.
BMJ Open|November 10, 2020
Implementation of the therapeutic use of hydroxyurea for sickle cell disease management in resource-constrained settings: a systematic review of adoption, cost and acceptabilityNessa Ryan, Lotanna Dike, Temitope Ojo, et al.
American Journal of Hematology|October 10, 2022
Blood diseases in Africa: Redressing unjust disparities is an urgent unmet needJulie Makani, Marina Cavazzana, Kalpna Gupta, et al.
Globalization and Health|February 18, 2021
Implementation science research for the scale-up of evidence-based interventions for sickle cell disease in africa: a commentaryJoyce Gyamfi, Temitope Ojo, Juliet Iwelunmor, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
The Lancet. Haematology|October 4, 2023
Sickle cell disease strategies and priorities - Authors' replyFrédéric B Piel, Michael R DeBaun, Obiageli Nnodu, et al.
Current Stem Cell Research & Therapy|February 22, 2022
HSC and miRNA Regulation with Implication for Foetal Haemoglobin Induction in Beta HaemoglobinopathiesChinwe Okeke, Ufele Silas, Obiageli Nnodu, et al.
Lancet (London, England)|July 13, 2024
Priorities for sickle cell disease global research and implementationAmbroise Wonkam, Nchangwi Syntia Munung, Aldiouma Guindo, et al.
BMJ Open|January 29, 2024
Protocol for a comparative cross-sectional study on characterisation of auditory impairment in sickle cell disease and sickle cell trait and its impact on health-related quality of life in NigeriaTitus S Ibekwe, Christine Rogers, Obiageli Nnodu, et al.
Pediatric Blood & Cancer|August 4, 2020
Accidental hydroxyurea overdosage in a child with sickle cell anemia: An African experienceUche Nnebe-Agumadu, Innocent Adogah Adebayo, Obiageli Nnodu, et al.
The Lancet. Haematology|October 6, 2024
The Global Fund should extend its mandate to include universal access to hydroxyureaIsaac Odame, Lêon Tshilolo, Julie Makani, et al.
Pediatric Blood & Cancer|March 31, 2021
Hydroxyurea in children with sickle cell disease in a resource-poor setting: Monitoring and effects of therapy. A practical perspectiveUche Nnebe-Agumadu, Innocent Adebayo, Ifeanyi Erigbuem, et al.
BMJ Open|November 10, 2020
Implementation of the therapeutic use of hydroxyurea for sickle cell disease management in resource-constrained settings: a systematic review of adoption, cost and acceptabilityNessa Ryan, Lotanna Dike, Temitope Ojo, et al.
American Journal of Hematology|October 10, 2022
Blood diseases in Africa: Redressing unjust disparities is an urgent unmet needJulie Makani, Marina Cavazzana, Kalpna Gupta, et al.
Globalization and Health|February 18, 2021
Implementation science research for the scale-up of evidence-based interventions for sickle cell disease in africa: a commentaryJoyce Gyamfi, Temitope Ojo, Juliet Iwelunmor, et al.
Pageof 4